|
Upcoming Conference
Presentations
Senior
members of Product Genesis' Strategic Innovation team have been invited to
speak at two premier conferences this spring. These conference papers are
part of Product Genesis' ongoing commitment to publish new findings that
advance the state-of-the-art in innovation.
Jeff
Hovis, Managing Principal at Product Genesis will lead the Technology
Convergence Track, and present at BioTech 2005 in Miami
Florida, March 10, 2005. Mr. Hovis' paper addresses the significant
innovation opportunities presented by the convergence of biotechnology
research, medical devices, clinical diagnostics and information technology.
Patrick
Casey, Director at Product Genesis, is a co-presenter of a case study at
the PDMA/IIR Front End of Innovation Conference in Boston,
MA, May 23-25. Mr. Casey's paper is titled "Seeing Around the Corner:
Using Scenarios to Identify New Market Opportunities".
Both
papers will be made available for download from Product Genesis' Innovation
Archive after the conference presentations.
Learn more about these conferences...
|
|
|
Dear Strategic Innovator,
Welcome to the January issue of Accelerating
Success, the Newsletter for Strategic Innovators. In each issue, we
try to bring you the latest information on tools, techniques and
successes from the application of Strategic Innovation to build value and
sustainable competitive advantage in companies like yours.
|
|
|
|
|
|
|
|
|
New Case Study: Identifying the Path to BioPharma Market
Success
|
|
|
Strategic Innovators often face market-timing issues when
they try to bring their innovations to market. Particularly in the life
sciences realm, long regulatory approval cycles, and lengthy adoption
timeframes can make it difficult for the new technology venture to
survive without near-term revenue opportunities.
For an
entrepreneurial new technology venture within a Global 1000
diversified technology company, a world leader in advanced medical
systems, Product Genesis applied our Opportunity Genesis framework
to deliver near-term market opportunities, while keeping the venture on
track to the ultimate clinical marketplace. Central to achieving a
successful market entry was identifying a non-regulated market
opportunity for the innovative technology that was closely aligned with
the final goal of in vivo diagnostics and clinical imaging
applications. The resulting path-to-market innovations allowed that
organization to develop early revenue, market and technology deployment
expertise, directly on the path to the eventual clinical marketplace
prize.
Download the Case Study (pdf)...
|
|
|
|
|
|
|
Support for Venture Capitalists
|
|
|
 Are you
challenged with vetting the market readiness and timing for technology
innovations? Are you looking to help your portfolio companies break out
of their first product success to capitalize on the full market potential
of their platform technologies?
The
Genesis suite of services support venture capitalists and private equity
investors seeking to maximize the value creation from technology
investments. The comprehensive suite of analytical frameworks provide the
basis for both individual technology and broad portfolio decisions, and
provide a mechanism to build real shareholder value from platform
technology investments.
Learn more...
|
|
|
|
|
|
